Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Liver-lung axes in alcohol-related liver disease

Gavin E. Arteel

Clin Mol Hepatol. 2020;26(4):670-676. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0174

View: 5481 Download: 118 Web of Science: 10 Crossref: 9

3

Clinical outcomes of systemic chemotherapy in hepatocellular carcinoma patients with multiple Lung metastases

Ki Tae Yoon, M.D. Jong Won Choi, M.D. Jun Yong Park, M.D. Sang Hoon Ahn, M.D., Ph.D. Yong Han Paik, M.D., Ph.D. Kwan Sik Lee, M.D., Ph.D. Kwang Hyub Han, M.D. Chae Yoon Chon, M.D. Do Young Kim, M.D.

Clin Mol Hepatol. 2008;14(3):360-370. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.360

View: 4532 Download: 21 Crossref: 5

4

Pulmonary Toxicity by Pegylated Interferon α-2a in a Patient with Chronic Hepatitis C

Byoung Kwan Son , Joo Hyun Sohn , Tae Yeob Kim , Yoon Kyung Park , Yong Chul Jeon , Dong Soo Han

Clin Mol Hepatol. 2007;13(1):103-107. Published online January 1, 1970

View: 2713 Download: 19

3

Clinical Outcome of Pulmonary Resections in Patients with Pulmonary Metastasis of Hepatocellular Carcinoma

Kyung Kyu Kim, M.D., Ja Kyung Kim, M.D., Do Young Kim, M.D., Sang Hoon Ahn, M.D., Chae Yoon Chon, M.D., Young Myoung Moon, M.D., Kyung Young Chung, M.D. and Kwang-Hyub Han, M.D.

Clin Mol Hepatol. 2005;11(4):350-358. Published online January 1, 1970

View: 2900 Download: 20

1 |

Viewed By 5360	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5312	MAFLD: How is it different from NAFLD?
Viewed By 5206	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3893	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3850	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search